|
|
|
|

Department of Neurology,
* Perinatal Nutrition and Development Unit, Department of Obstetrics and Gynaecology and
** Department of Pathology and Laboratory Medicine, University Hospital, University of Groningen, Groningen, The Netherlands and
Numico Research Germany, Friedrichsdorf, Germany
2 To whom correspondence should be addressed. E-mail: m.hadders-algra{at}med.rug.nl.
To investigate the minimal duration of exclusive breastfeeding for optimal neurological outcome, we assessed the quality of general movements (GM) at 3 mo of 147 breastfed healthy term infants that were followed from birth. The quality of GM is a sensitive marker of neurological condition. The quality of GM was classified as normal-optimal, normal-suboptimal, mildly abnormal and definitely abnormal. Information on social and pre- and perinatal conditions and the duration of breastfeeding was collected prospectively. Logistical regression analyses were used to adjust for confounders. There was a positive association between breastfeeding duration and movement quality, with a saturation effect at the age of
6 wk. In the group of infants breastfed for
6 wk (n = 55), 18% exhibited normal-optimal GM, 47% normal-suboptimal GM, and 47% mildly abnormal GM. In contrast, in the group of infants breastfed for > 6 wk (n = 92), 43% exhibited normal-optimal GM, 45% normal-suboptimal GM, and 12% mildly abnormal GM. Exclusive breastfeeding for >6 wk was therefore associated with markedly less abnormal and more normal-optimal GM. Thus, we conclude that breastfeeding for > 6 wk might improve the neurological condition in infants.
KEY WORDS: breastfeeding general movements development term infant
This article has been cited by other articles:
![]() |
A. Sacker, M. A. Quigley, and Y. J. Kelly Breastfeeding and Developmental Delay: Findings From the Millennium Cohort Study Pediatrics, September 1, 2006; 118(3): e682 - e689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C McCann and B. N Ames Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am. J. Clinical Nutrition, August 1, 2005; 82(2): 281 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, January 10, 2004; 328(7431): 116 - 116. [Full Text] [PDF] |
||||